Ubs Group Ag Zai Lab LTD Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Zai Lab LTD stock. As of the latest transaction made, Ubs Group Ag holds 18,258 shares of ZLAB stock, worth $478,907. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,258

Previous 43,485 58.01%

Holding current value

$478,907

Previous $753,000 41.57%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$16.25 - $24.14 $409,938 - $608,979	-25,227 Reduced 58.01%	18,258 $440,000
Q2 2024 Aug 13, 2024	SELL	$13.72 - $21.55 $539,168 - $846,871	-39,298 Reduced 47.47%	43,485 $753,000
Q1 2024 May 13, 2024	BUY	$15.95 - $26.8 $922,388 - $1.55 Million	57,830 Added 231.76%	82,783 $1.33 Million
Q4 2023 Feb 09, 2024	SELL	$22.97 - $30.58 $6.06 Million - $8.07 Million	-264,028 Reduced 91.37%	24,953 $681,000
Q3 2023 Nov 09, 2023	BUY	$22.72 - $31.49 $4.97 Million - $6.89 Million	218,907 Added 312.39%	288,981 $7.03 Million
Q2 2023 Aug 11, 2023	SELL	$25.3 - $39.67 $3.22 Million - $5.06 Million	-127,443 Reduced 64.52%	70,074 $1.94 Million
Q1 2023 May 12, 2023	SELL	$30.21 - $48.1 $653,865 - $1.04 Million	-21,644 Reduced 9.88%	197,517 $6.57 Million
Q4 2022 Feb 08, 2023	BUY	$22.28 - $38.71 $1.52 Million - $2.64 Million	68,205 Added 45.18%	219,161 $6.73 Million
Q3 2022 Nov 10, 2022	SELL	$34.2 - $51.69 $48,769 - $73,709	-1,426 Reduced 0.94%	150,956 $5.16 Million
Q2 2022 Aug 10, 2022	BUY	$23.14 - $49.68 $46,395 - $99,608	2,005 Added 1.33%	152,382 $5.29 Million
Q1 2022 May 16, 2022	SELL	$27.77 - $64.4 $2.14 Million - $4.97 Million	-77,170 Reduced 33.91%	150,377 $6.61 Million
Q4 2021 Feb 14, 2022	SELL	$54.9 - $105.21 $1.44 Million - $2.75 Million	-26,153 Reduced 10.31%	227,547 $14.3 Million
Q3 2021 Nov 15, 2021	BUY	$105.0 - $178.37 $3.97 Million - $6.75 Million	37,845 Added 17.53%	253,700 $26.7 Million
Q2 2021 Aug 13, 2021	BUY	$125.11 - $180.0 $2.87 Million - $4.13 Million	22,963 Added 11.9%	215,855 $38.2 Million
Q1 2021 May 12, 2021	BUY	$126.27 - $191.71 $380,198 - $577,238	3,011 Added 1.59%	192,892 $25.7 Million
Q4 2020 Feb 11, 2021	SELL	$81.94 - $135.34 $10.3 Million - $17.1 Million	-126,303 Reduced 39.95%	189,881 $25.7 Million
Q3 2020 Nov 12, 2020	BUY	$73.3 - $89.48 $6.3 Million - $7.69 Million	85,950 Added 37.33%	316,184 $26.3 Million
Q2 2020 Jul 31, 2020	SELL	$48.82 - $82.53 $543,073 - $918,063	-11,124 Reduced 4.61%	230,234 $18.9 Million
Q1 2020 May 01, 2020	BUY	$39.1 - $62.9 $3.73 Million - $6 Million	95,358 Added 65.31%	241,358 $12.4 Million
Q4 2019 Feb 14, 2020	BUY	$29.79 - $43.06 $4.35 Million - $6.29 Million	146,000 New	146,000 $6.07 Million
Q1 2019 May 14, 2019	SELL	$21.71 - $31.54 $27,007 - $39,235	-1,244 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$14.95 - $24.72 $41,351 - $68,375	-2,766 Reduced 68.98%	1,244 $29,000
Q3 2018 Nov 14, 2018	BUY	$17.8 - $25.35 $71,378 - $101,653	4,010 New	4,010 $78,000
Q2 2018 Aug 14, 2018	SELL	$18.0 - $25.01 $9,594 - $13,330	-533 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$20.05 - $26.96 $10,686 - $14,369	533 New	533 $11,000
Q4 2017 Feb 14, 2018	SELL	$21.23 - $34.09 $36,834 - $59,146	-1,735 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$27.0 - $31.11 $46,845 - $53,975	1,735	1,735 $47,000

Others Institutions Holding ZLAB

# of Institutions

121

Shares Held

46.7M

Call Options Held

223K

Put Options Held

588K

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.57B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account